HIT BANGLA

Bangla Hit Collection and Download Website

Indo Bangla Pharmaceuticals Ltd.: Company Information & Result

UPDATE: High Court was declared six months  suspend to receive subscription of Indo Bangla Pharmaceuticals Ltd.

UPDATE: As per final prospectus, Indo Bangla Pharmaceuticals Ltd. subscription will start from 8 April’18 to 18 April’18 (Including NRB).

The Bangladesh Securities Exchange Commission (BSEC) approved IPO “Indo Bangla Pharmaceuticals Ltd.” on Tuesday, 3rd October 2017 at their 613 nos Board Meeting. Presided by BSEC Chairman Prof. Dr M Khairul Hossain to issue 2.00 crore ordinary shares worth Tk 10 each. Company Information, IPO Application Form, Prospectus & Result is given below:

COMPANY NAME:

Indo-Bangla Pharmaceuticals Ltd., the flagship company of IBP group was established in 1954, incorporated as a private limited company under the Companies Act on June 18, 2014, and converted into a public limited company on October 21, 2014. From the inception in 1954 Indo-Bangla Pharmaceuticals Ltd. has stood for quality, business success and responsible entrepreneurship.

Indo Bangla Pharmaceuticals Ltd.

NATURE OF BUSINESS:

Healthcare is one of the important factors among the fundamental need of human being. Since the established of Indo-Bangla Pharmaceuticals Ltd., it has been aiming to fulfil this fundamental demand of the people of Bangladesh and is committed to reaching the healthcare service to the doorstep of the common people and all over the world. IBPL believe that the experience and skill of the physician supported with quality medicines can only ensure better human life.

IBPL are an ISO 9001:2008 certified company and committed to improving the quality of human life by enabling people to do more, feel better and live longer. IBPL also believe and adhere to values like Quality, Knowledge and Responsibility in all aspects of its operation and earned respect and recognition of its valued customers in the healthcare sector of Bangladesh.

PRODUCTS

There are many medicine produce by IBPL but for your kind information here ten approved Products given below:

  1. Tablet I–Cet -10mg
  2. Tablet Trialugel – 250mg & 400mg
  3. Tablet Indomol Plus -500mg & 65mg
  4. Tablet Indo-Fila 100mg
  5. Tablet Indosin
  6. Tablet I-Fol
  7. Tablet I-Fol  Plus
  8. Tablet Mebendox  100mg
  9. Tablet Albendox 400mg
  10. Tablet Sulbumol 2.0mg

Indo Bangla Pharmaceuticals Ltd.

 ADDRESS:

Corporate Office: House#11/1, Jahan Tower Flat-B2(2nd Floor), Road: Murad Sarak, Avoy Das lane, Dhaka-1203.

Registered Office & Factory: Add-Aziz Bhaban, H/N:0729-000,
College Road, Barisal Sadar, Barisal-8200.
Phone: +88 0431 2174811, +88 0431 2174977
Fax: ++88-02-57164716 (Ext-101)
Email: info@indo-banglapharma.com 
Web Address: www.indo-banglapharma.com

TWO YEAR MAJOR FINANCIAL INFORMATION AS FOLLOWS:

Particulars 30-06-16
Taka
30-06-15
Taka
Revenue 444,777,724 435,024,108
Gross Profit  182,248,732 177,140,449
Net Profit before tax  90,807,238 92,629,642
Net Profit after tax  59,024,705 60,209,267
Total Assets  945,378,813 383,019,532
Share Capital  730,000,000 99,000,000
Retained Earnings  119,233,972 60,209,267
No. of Shares  73,000,000 9,900,000
Face Value  10.00 10.00
NAV per Shares  11.63 16.08
Earnings per Share (Basic)  2.62 6.40

INDO BANGLA PHARMACEUTICALS LTD. EPS & NAV:

As per company’s year ended financial statement on 30 June 2016, Indo Bangla Pharmaceuticals Ltd. stands Net Assets Value per shares Tk. 11.63 and Earning Per Shares (EPS) at Tk. 2.62.

ISSUE MANAGER:

AFC Capital Ltd., EBL Investment Ltd. and CAPM Advisory Ltd. are jointly working as the manager to the issue.

WHY PUBLIC OFFERING:

Bangladesh Securities Exchange Commission (BSEC) approved IPO of above Co. on 3 October 2017. The companies will raise a fund worth Tk. 200.00 million for the purpose of acquisition of Plant & Machinery and Construction of the new factory building, Administration building, Go-down, Garaged and IPO expenses meet from IPO proceeds.

NOS. OF SHARE OFFER: 20,000,000 
VALUE OF IPO: Tk. 200,000,000/=
FACE VALUE: Tk. 10/=
PREMIUM VALUE: Nil
MARKET LOT:500
MINIMUM LOT VALUE:
Tk.5000.-
SHARE ALLOTMENT: 40% for General Public and Affected Investors=16,000 lot, 40% for Eligible Investor (EI)  =16,000 lot, 10% for NRB = 4,000 lot and 10% for Mutual Fund = 4,000 lot.

** The Company will collect IPO money through BSEC new rules and the new rule is “BROKER HOUSE SHOULD COLLECT IPO MONEY ONLY”.

SUBSCRIPTION DATE:

The Company’s subscription date will start from 08 April’18 to 18 April’18 and Final Prospectus coming soon. 

DOWNLOAD IPO FORM HERE:

Res./EI./NRB Application Form

INDO BANGLA PHARMACEUTICALS LTD.: DRAFT PROSPECTUS
INDO BANGLA PHARMACEUTICALS LTD.: TT Clean Rate 13.03.18
INDO BANGLA PHARMACEUTICALS LTD.: Lot Wise Rate 13.03.18

I

DOWNLOAD LOTTERY RESULT HERE:
YET TO BE PUBLISHED

Stock Broker / Merchant Bank Code

General Public

Affected Investors

Non-Residence Bangladeshi (NRB)

Eligible Investors 

Mutual Fund

 THANK YOU FOR VISITING HITBANGLA.COM.

Incoming search terms:

indo bangla ipo news bd, indo bangla pharma bd, indo bangla pharmaceutical, Indo-Bangla ipo news, indo-bangla pharma, number of share of indo bangla pharma ltd, www indo bangla pharma bd com

The Author

Leave a Reply

HIT BANGLA © 2018